
Dr Nico AF Janssen
Doctor of Medicine. Consultant in Infectious DiseasesDr. Nico A.F. Janssen is a Consultant in Infectious Diseases at Wythenshawe Hospital, part of the Manchester University NHS Foundation Trust (MFT).
Professional Background:
-
Clinical Role:
- As a Consultant in Infectious Diseases, Dr. Janssen specializes in diagnosing and managing complex infectious diseases.
-
Research and Publications:
- Dr. Janssen has an extensive research portfolio with 38 publications and over 1,600 citations. His research interests include fungal infections, mycology, fungal immunology, and viral pneumonitis-associated invasive aspergillosis.
- He has co-authored several studies on pulmonary aspergillosis eg.:
- Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial. Vanderbeke L, Janssen NAF, et.al., Intensive Care Med. 2021 Jun;47(6):674-686. doi: 10.1007/s00134-021-06431-0.
- A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology.
J Fungi (Basel). 2020 Nov 10;6(4):274. doi: 10.3390/jof6040274.
- Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis.
Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174.
- Dr. Janssen has co-authored a book chapter on pulmonary aspergillosis with Dr. Chris Kosmidis: Kosmidis, C., Janssen, N. (2024). Spectrum of Chronic Pulmonary Aspergillosis. In: Soubani, A.O. (eds) Pulmonary Aspergillosis. Springer, Cham. https://doi.org/10.1007/978-3-031-76524-7_16
-
Previous Experience:
- Before joining MFT, Dr. Janssen served as an Infectious Diseases specialist and Ph.D. candidate at Radboud University Medical Center in Nijmegen, the Netherlands, from August 2017 to July 2021.
Dr. Janssen’s work significantly contributes to the understanding and management of fungal infections, particularly in critically ill patients.
GMC: 7894933